Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease

Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease

Abstract Background Obstructive sleep apnoea (OSA) has a high prevalence in patients with Alzheimer’s disease (AD). Both conditions have been shown to be associated with lipid dysregulation. However, the relationship between OSA severity and alterations in lipid metabolism in the brains of patients...

Full description

Bibliographic Details
Main Authors: Farida Dakterzada, Iván D. Benítez, Adriano Targa, Anna Carnes, Montse Pujol, Mariona Jové, Olga Mínguez, Rafi Vaca, Manuel Sánchez-de-la-Torre, Ferran Barbé, Reinald Pamplona, Gerard Piñol-Ripoll
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
Biomarker
Cerebrospinal fluid
Diagnosis
Lipidomics
Obstructive sleep apnoea
Online Access:https://doi.org/10.1186/s13195-023-01278-7

Internet

https://doi.org/10.1186/s13195-023-01278-7

Similar Items